Articles tagged with: HIV

Feb14

Striving for a worry-free Valentine's Day...and every other day

Wednesday, 14 February 2018 Tags // Advocacy, AGYW, Contraception, End-User, HIV, STIs

“It finally happened! We had sex! And how romantic that it was on Valentine’s Day, right?” Jen, one of the first friends I made in college, could barely contain herself as she shared this news while walking with me to the university café. She then hesitated, “The only thing is, he didn’t have a condom. Do you think I’ll be okay?”

Dec21

ICYMI: Discussion on end-user research for MPT R&D

Thursday, 21 December 2017 Tags // Contraception, End-User, HIV, Product, Reproductive Health, Research

At this point, we do not likely need to convince you that if you are aiming to develop and introduce an MPT product, incorporating end-user research into the process is a good idea, especially if you want it to have a positive public health impact. We at the IMPT Secretariat are delighted that end-user research has become an increased focus in the contraception, HIV prevention, and global health spaces. It is now critical that enthusiasm for end-user research in these fields is applied effectively – that is, employs the right methods with the right stakeholders during the right stages, asks questions that fill knowledge gaps rather than ‘reinvent the wheel,’ and otherwise addresses past challenges experienced with this type of research.

Nov29

Status of the field: MPTs in the product pipeline

Wednesday, 29 November 2017 Tags // Contraception, HIV, Pipeline, Product, Reproductive Health, STIs

Since 2009, when MPTs officially became a “thing,” we have had a lot of conversations about MPTs and answered even more questions. We have spoken with friends, family, colleagues, neighbors, seatmates on plane flights – you name it. Until recently, not many people had heard of MPTs, and we spent a large part of these conversations doing quite a bit of explaining.

Most people we talk to seem universally on board with the concept of MPTs, thinking that it “just makes sense” as a prevention approach. However, because there aren’t many ready-to-use MPTs on the market (condoms being the sole exception) they are also hesitant to get “too excited” about future products still in development. For many, MPTs sound great – but intangible, disconnected from reality.

Nov02

Will you join us?

Thursday, 02 November 2017 Tags // Advocacy, AGYW, Contraception, HIV, Reproductive Health, Risk, Sexual Health

It remains unacceptable that women and girls worldwide continue to confront preventable sexually transmitted infections (STIs), including HIV, as well as face high rates of unintended pregnancies. It is unacceptable that advocates, scientists, and politicians still need to convince people that investing in, innovating around, and creating a supportive policy environment for women’s health is imperative. Public health figures should speak for themselves –  women need access, innovation, more options for disease and pregnancy prevention. It has been nearly 40 years since the emergence of the HIV/AIDS epidemic, 60 years since the first birth control pill became available, and 90 years since penicillin was discovered and became a successful treatment for bacterial STIs. While many critical advances have been made in the decades following these sexual and reproductive health milestones, the continued suffering of millions of women worldwide means that we, as a public health community, need to do better.

Recent Posts

Any thoughts? Contact us to learn more about the submission process.

Share

Spread the word about the promise of MPTs.

Collaborate

We will go further together – join the movement for MPTs.

Contribute

Your financial and in-kind support can help make MPTs a reality.